{"id":12380,"date":"2016-11-22T22:56:41","date_gmt":"2016-11-23T01:56:41","guid":{"rendered":"https:\/\/www.tiabeth.com.br\/?p=12380"},"modified":"2016-11-22T22:56:41","modified_gmt":"2016-11-23T01:56:41","slug":"sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2","status":"publish","type":"post","link":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/","title":{"rendered":"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2"},"content":{"rendered":"<figure id=\"attachment_12381\" aria-describedby=\"caption-attachment-12381\" style=\"width: 1000px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg\"><img loading=\"lazy\" class=\"size-full wp-image-12381\" src=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg\" alt=\"(insulin glargine &amp; lixisenatide injection) 100 Units\/mL &amp; 33 mcg\/mL for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin\" width=\"1000\" height=\"650\" srcset=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg 1000w, https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua-300x195.jpg 300w, https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua-768x499.jpg 768w, https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua-765x496.jpg 765w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><\/a><figcaption id=\"caption-attachment-12381\" class=\"wp-caption-text\">Soliqua \u00e9 uma combina\u00e7\u00e3o de insulina glargina &amp; lixisenatide. Vem em inje\u00e7\u00f5es de 100 Units\/mL &amp; 33 mcg\/mL<\/figcaption><\/figure>\n<p>Nesta ter\u00e7a-feira, o Food and Drug Administration (FDA), \u00f3rg\u00e3o de controle de alimentos e medicamentos dos EUA, aprovou a venda de <em>Soliqua<\/em>, um novo medicamento para o diabetes indicado para tratamento de adultos com o tipo 2 inadequadamente controlados e que fazem uso da insulina basal.<\/p>\n<p>A autoriza\u00e7\u00e3o do FDA permitir\u00e1 \u00e0 Sanofi comercializar o novo tratamento nos EUA, e faz parte dos esfor\u00e7os da companhia para compensar uma queda esperada na receita ap\u00f3s a perda de prote\u00e7\u00e3o de patentes de seu tratamento com a insulina Lantus.<\/p>\n<p><em>Soliqua<\/em> \u00e9 resultante da combina\u00e7\u00e3o de dois f\u00e1rmacos j\u00e1 existentes no mercado, incluindo a Lantus e Lixisenatide (um agonista GLP-1). Sanofi diz que uma \u00fanica dose di\u00e1ria da mistura vai permitir que o paciente venha a melhorar o controle do n\u00edvel de glicemia.<\/p>\n<p>O\u00a0FDA \u00e9 o primeiro \u00f3rg\u00e3o regulador a aprovar a comercializa\u00e7\u00e3o de Soliqua.<\/p>\n<p>A companhia, sediada em Paris, \u00e9 uma das maiores fabricantes mundiais de medicamentos para diabetes.\u00a0No entanto, parte do neg\u00f3cio est\u00e1 sob press\u00e3o dos sistemas de cuidados de sa\u00fade cada vez mais conscientes dos custos. A empresa espera que a receita de medicamentos para a diabetes venha a diminuir \u00e0 medida que a\u00a0concorr\u00eancia entre os fabricantes de insulina se intensifica.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.marketwatch.com\/story\/sanofi-gets-fdas-ok-to-sell-diabetes-drug-soliqua-2016-11-22\" target=\"_blank\">http:\/\/www.marketwatch.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nesta ter\u00e7a-feira, o Food and Drug Administration (FDA), \u00f3rg\u00e3o de controle de alimentos e medicamentos dos EUA, aprovou a venda de Soliqua, um novo medicamento para o diabetes indicado para tratamento de adultos com o tipo 2 inadequadamente controlados e que fazem uso da insulina basal. A autoriza\u00e7\u00e3o do FDA permitir\u00e1 \u00e0 Sanofi comercializar o [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12381,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[19,196],"tags":[28,45,3635,3634,1203,3633],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2 - TiaBeth.com<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\" \/>\r\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2 - TiaBeth.com\" \/>\r\n<meta property=\"og:description\" content=\"Nesta ter\u00e7a-feira, o Food and Drug Administration (FDA), \u00f3rg\u00e3o de controle de alimentos e medicamentos dos EUA, aprovou a venda de Soliqua, um novo medicamento para o diabetes indicado para tratamento de adultos com o tipo 2 inadequadamente controlados e que fazem uso da insulina basal. A autoriza\u00e7\u00e3o do FDA permitir\u00e1 \u00e0 Sanofi comercializar o [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\" \/>\r\n<meta property=\"og:site_name\" content=\"TiaBeth.com\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/tiabethcom\" \/>\r\n<meta property=\"article:published_time\" content=\"2016-11-23T01:56:41+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\r\n\t<meta property=\"og:image:height\" content=\"650\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"nlimonge\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:site\" content=\"@tiabethcom\" \/>\r\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"nlimonge\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982\",\"name\":\"Raquel Limonge\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg\",\"contentUrl\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg\",\"width\":856,\"height\":856,\"caption\":\"Raquel Limonge\"},\"logo\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/tiabethcom\",\"https:\/\/www.instagram.com\/raqueltiabeth\",\"https:\/\/twitter.com\/https:\/\/www.twitter.com\/tiabethcom\"]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#website\",\"url\":\"https:\/\/www.tiabeth.com.br\/\",\"name\":\"TiaBeth.com\",\"description\":\"O maior conte\u00fado sobre diabetes da l\u00edngua portuguesa\",\"publisher\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.tiabeth.com.br\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#primaryimage\",\"url\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg\",\"contentUrl\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg\",\"width\":1000,\"height\":650,\"caption\":\"(insulin glargine & lixisenatide injection) 100 Units\/mL & 33 mcg\/mL for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\",\"url\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\",\"name\":\"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2 - TiaBeth.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#primaryimage\"},\"datePublished\":\"2016-11-23T01:56:41+00:00\",\"dateModified\":\"2016-11-23T01:56:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/www.tiabeth.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\"},\"author\":{\"name\":\"nlimonge\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b\"},\"headline\":\"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2\",\"datePublished\":\"2016-11-23T01:56:41+00:00\",\"dateModified\":\"2016-11-23T01:56:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/\"},\"wordCount\":272,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982\"},\"image\":{\"@id\":\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg\",\"keywords\":[\"diabetes\",\"glargina\",\"gpl 1\",\"lixisenatide\",\"sanofi\",\"soliqua\"],\"articleSection\":[\".Not\u00edcia\",\"Medicamento\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b\",\"name\":\"nlimonge\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g\",\"caption\":\"nlimonge\"},\"url\":\"https:\/\/www.tiabeth.com.br\/index.php\/author\/nlimonge\/\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2 - TiaBeth.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/","og_locale":"pt_BR","og_type":"article","og_title":"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2 - TiaBeth.com","og_description":"Nesta ter\u00e7a-feira, o Food and Drug Administration (FDA), \u00f3rg\u00e3o de controle de alimentos e medicamentos dos EUA, aprovou a venda de Soliqua, um novo medicamento para o diabetes indicado para tratamento de adultos com o tipo 2 inadequadamente controlados e que fazem uso da insulina basal. A autoriza\u00e7\u00e3o do FDA permitir\u00e1 \u00e0 Sanofi comercializar o [&hellip;]","og_url":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/","og_site_name":"TiaBeth.com","article_publisher":"https:\/\/www.facebook.com\/tiabethcom","article_published_time":"2016-11-23T01:56:41+00:00","og_image":[{"width":1000,"height":650,"url":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg","type":"image\/jpeg"}],"author":"nlimonge","twitter_card":"summary_large_image","twitter_site":"@tiabethcom","twitter_misc":{"Escrito por":"nlimonge","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Person","Organization"],"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982","name":"Raquel Limonge","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/","url":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg","contentUrl":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2022\/07\/logo_tiabeth.jpg","width":856,"height":856,"caption":"Raquel Limonge"},"logo":{"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/"},"sameAs":["https:\/\/www.facebook.com\/tiabethcom","https:\/\/www.instagram.com\/raqueltiabeth","https:\/\/twitter.com\/https:\/\/www.twitter.com\/tiabethcom"]},{"@type":"WebSite","@id":"https:\/\/www.tiabeth.com.br\/#website","url":"https:\/\/www.tiabeth.com.br\/","name":"TiaBeth.com","description":"O maior conte\u00fado sobre diabetes da l\u00edngua portuguesa","publisher":{"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.tiabeth.com.br\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#primaryimage","url":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg","contentUrl":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg","width":1000,"height":650,"caption":"(insulin glargine & lixisenatide injection) 100 Units\/mL & 33 mcg\/mL for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin"},{"@type":"WebPage","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/","url":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/","name":"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2 - TiaBeth.com","isPartOf":{"@id":"https:\/\/www.tiabeth.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#primaryimage"},"datePublished":"2016-11-23T01:56:41+00:00","dateModified":"2016-11-23T01:56:41+00:00","breadcrumb":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.tiabeth.com.br\/"},{"@type":"ListItem","position":2,"name":"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2"}]},{"@type":"Article","@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#article","isPartOf":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/"},"author":{"name":"nlimonge","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b"},"headline":"Sanofi recebe autoriza\u00e7\u00e3o do FDA para comercializar Soliqua, nova droga para diabetes tipo 2","datePublished":"2016-11-23T01:56:41+00:00","dateModified":"2016-11-23T01:56:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/"},"wordCount":272,"commentCount":0,"publisher":{"@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/a2f986446141f19f046fea5ed1b20982"},"image":{"@id":"https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tiabeth.com.br\/wp-content\/uploads\/2016\/11\/soliqua.jpg","keywords":["diabetes","glargina","gpl 1","lixisenatide","sanofi","soliqua"],"articleSection":[".Not\u00edcia","Medicamento"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.tiabeth.com.br\/index.php\/2016\/11\/22\/sanofi-recebe-autorizacao-do-fda-para-comercializar-soliqua-nova-droga-para-diabetes-tipo-2\/#respond"]}]},{"@type":"Person","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/33351de1d946f0c455b0ea4849d64e5b","name":"nlimonge","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.tiabeth.com.br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bde7fe3c455e68f4f9028e3f52b1d758?s=96&d=mm&r=g","caption":"nlimonge"},"url":"https:\/\/www.tiabeth.com.br\/index.php\/author\/nlimonge\/"}]}},"_links":{"self":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/posts\/12380"}],"collection":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/comments?post=12380"}],"version-history":[{"count":0,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/posts\/12380\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/media\/12381"}],"wp:attachment":[{"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/media?parent=12380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/categories?post=12380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tiabeth.com.br\/index.php\/wp-json\/wp\/v2\/tags?post=12380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}